TGFB1 and neoplasm: In mice inoculated with 4T1 mammary carcinoma, treatment with cyclophosphamide and anti- TGFβ mAb decreased tumor growth, resulted in massive infiltration of IFNγ producing lymphocytes, and upregulated MHC II and CD80 on APCs.